Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 13 matching records.
13 results — page 1 of 1
- Level BRandomized Controlled TrialPubMed
Evaluation of Multiple Intravenous Infusions of Autologous Adipose-Derived Mesenchymal Stem Cells in Parkinson's Disease: A Randomized, Double-Blind Clinical Trial.
Randomized Controlled Trial with a reported sample of 24 on Neuroinflammation, published in Parkinsons Dis (2026) — summary generated from the PubMed abstract.
- 2026
- n = 24
Parkinsons Dis - Level CProspective StudyPubMed
Safety and Potential Effect of Intrauterine Infusion of Autologous Adipose Tissue-Derived Regenerative Cells in Patients With Implantation Failure: A Pilot Study.
Prospective Study on Systemic / IV, published in Cureus (2024) — summary generated from the PubMed abstract.
- 2024
Cureus3 citations - Level CCase Report / SeriesPubMed
Functional recovery of a 41-year-old quadriplegic spinal cord injury patient following multiple intravenous infusions of autologous adipose-derived mesenchymal stem cells: a case report.
Case Report / Series on Spinal Cord Injury, published in Front Transplant (2023) — summary generated from the PubMed abstract.
- 2023
Front Transplant - Level CProspective StudyPubMed
Repeated infusion of autologous adipose tissue-derived stem cells for Parkinson's disease.
Prospective Study on Neuroinflammation, published in Acta Neurol Scand (2021) — summary generated from the PubMed abstract.
- 2021
Acta Neurol Scand12 citations - Level CProspective StudyPubMed
Intrathecal Infusion of Autologous Adipose-Derived Regenerative Cells in Autoimmune Refractory Epilepsy: Evaluation of Safety and Efficacy.
Prospective Study on Autoimmune Research, published in Stem Cells Int (2020) — summary generated from the PubMed abstract.
- 2020
Stem Cells Int18 citations - Level BClinical TrialPubMed
Regenerative Therapy for Liver Cirrhosis Based on Intrahepatic Arterial Infusion of Autologous Subcutaneous Adipose Tissue-Derived Regenerative (Stem) Cells: Protocol for a Confirmatory Multicenter Uncontrolled Clinical
Clinical Trial, published in JMIR Res Protoc (2020) — summary generated from the PubMed abstract.
- 2020
JMIR Res Protoc - Level BClinical TrialPubMed
Systemic Infusion of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells in Peritoneal Dialysis Patients: Feasibility and Safety.
Clinical Trial on Chronic Kidney Disease, published in Cell J (2018) — summary generated from the PubMed abstract.
- 2018
Cell J22 citations - Level BClinical TrialPubMed
Phase I clinical study of liver regenerative therapy for cirrhosis by intrahepatic arterial infusion of freshly isolated autologous adipose tissue-derived stromal/stem (regenerative) cell.
Clinical Trial on Immune Modulation, published in Regen Ther (2017) — summary generated from the PubMed abstract.
- 2017
Regen Ther - Level CProspective StudyPubMed
Infusion of autologous adipose tissue derived neuronal differentiated mesenchymal stem cells and hematopoietic stem cells in post-traumatic paraplegia offers a viable therapeutic approach.
Prospective Study on Spinal Cord Injury, published in Adv Biomed Res (2016) — summary generated from the PubMed abstract.
- 2016
Adv Biomed Res - Level DAnimal StudyPubMed
Effects of autologous adipose-derived stem cell infusion on type 2 diabetic rats.
Animal Study on Systemic / IV, published in Endocr J (2015) — summary generated from the PubMed abstract.
- 2015
Endocr J37 citations - Level CCase Report / SeriesPubMed
Co-infusion of autologous adipose tissue derived neuronal differentiated mesenchymal stem cells and bone marrow derived hematopoietic stem cells, a viable therapy for post-traumatic brachial plexus injury: a case report.
Case Report / Series on Back & Spine, published in Biomed J (2014) — summary generated from the PubMed abstract.
- 2014
Biomed J - Level CProspective StudyPubMed
Co-infusion of autologous adipose tissue derived insulin-secreting mesenchymal stem cells and bone marrow derived hematopoietic stem cells: viable therapy for type III.C. a diabetes mellitus.
Prospective Study on Systemic / IV, published in Biomed J (2013) — summary generated from the PubMed abstract.
- 2013
Biomed J - Level CProspective StudyPubMed
Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells.
Prospective Study with a reported sample of 10 on Neuroinflammation, Autoimmune Research, published in J Transl Med (2011) — summary generated from the PubMed abstract.
- 2011
- n = 10
J Transl Med124 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406